Incontinence, Urge: Clinical Trials

3 trials for Incontinence, Urge, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Completed 1

Follow Incontinence, Urge: new trials by email Literature Review of Incontinence, Urge trials Research Report on Incontinence, Urge

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TReating Incontinence for Underlying Mental and Physical Health
Tolterodine Tartrate ER, Mirabegron, Placebo - Urinary Incontinence, Urge, Urinary Incontinence
Phase 4RecruitingUniversity of California, San Francisco2702022-10-042026-03-06
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
OnabotulinumtoxinA 100 UNT - Urinary Bladder, Overactive, Incontinence, Urge
Phase 4RecruitingUniversity of South Florida602019-10-092020-11-05
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
Anticholinergic, Beta-3 Agonists, Adrenergic, Functional magnetic resonance imaging (fMRI) - Overactive Bladder, Dementia
Phase 4CompletedBaylor Research Institute122019-08-052024-02-02

Narrower conditions

Urinary Bladder, Overactive (3)  ·  Urinary Incontinence, Urge (3)  ·  Urinary Incontinence (2)  ·  Dementia (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Nocturia (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Urinary Bladder Diseases (3)  ·  Urination Disorders (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Urological Manifestations (3)  ·  Lower Urinary Tract Symptoms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)

Interventions

mirabegron (2)  ·  Adrenergic beta-3 Receptor Agonists (1)  ·  Botulinum Toxins, Type A (1)  ·  Cholinergic Antagonists (1)  ·  Magnetic Resonance Imaging (1)  ·  Solifenacin Succinate (1)  ·  Tolterodine Tartrate (1)

Sponsors

Baylor Research Institute (1)  ·  University of California, San Francisco (1)  ·  University of South Florida (1)

Countries

United States (3)

Top investigators

Alison Huang, MD, MAS, MPhil (1)  ·  Eric S Chang, MD (1)  ·  Jill Danford, MD (1)  ·  Rachel High, DO (1)  ·  Rose Khavari, MD (1)

Results publications

PMID 35543540, PMID 37085880, PMID 37160401

NIH funding

R01AG075471 (1)